Article

Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal…

Stem Cells International · 2019 · Maria L. Alonso-Alonso, author Girish K. Srivastava, author Ricardo Usategui-Martín, author Maria T. García-Gutierrez, author José Carlos Pastor, author Ivan Fernandez-Bueno, author Yuriy Petrenko, Academic Editor

Key facts

Title Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases
First author Maria L. Alonso-Alonso, author Girish K. Srivastava, author Ricardo Usategui-Martín, author Maria T. García-Gutierrez, author José Carlos Pastor, author Ivan Fernandez-Bueno, author Yuriy Petrenko, Academic Editor
Journal Stem Cells International
Published Dec 17, 2019
DOI 10.1155/2020/9463548
Devices mentioned 079093, BK110039, DEN000008, K022086, K103302
Product codes mentioned JCI, KIP, KIT, NDS, NJT, OOI, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature